Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases. […]
Biologics
Stay informed on the latest in biologic medicines with Biologics Insights. Explore trends, research updates, regulatory news, and innovations in therapeutic biologics, biosimilars, and advanced biologic treatments.
Biologics and Biosimilars Registration Process in China (NMPA)
Biologics and Biosimilars hold great therapeutic value, as they are the emerging class of pharmaceuticals products. They hold the potential
Biologics & Biosimilar Regulations in European Union (EU) (EMA)
In Europe, biologics and biosimilars are evaluated through a lens of scientific comparability and public health responsibility. For executives, this
Biologics and Biosimilar Regulation and Registration in Japan (PMDA)
With the exception of the United States, Japan’s biosimilar business, with a market value of $140 million, accounted for just
Biosimilars: Affordable and Effective Alternatives to Biologics
Biosimilars are biologic medical products that are highly similar to an already approved reference biologic drug. They are designed to
Hong Kong: New Drugs, Generics, Biosimilars Regulations
Hong Kong- New Drugs, Generics, Biosimilar Regulations: Hong Kong has a robust regulatory system for pharmaceuticals, overseen by the Department
Biologics and Biosimilars Regulations, Registration Process in the USA (FDA)
The size of the U.S. biosimilars market, estimated at USD 6.73 billion in 2021, is expected to increase by USD
New Drugs, Generics and Biosimilars Registration in Singapore: Whitepaper on HSA Regulations
Singapore stands as a beacon of regulatory excellence in the pharmaceutical industry, offering a robust framework that ensures the safety,
Biologics and Biosimilars Regulations and Registration in Brazil
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales